SCHEMBL4848837

SCHEMBL4848837

CC(C)(C)C(O[SiH](c1ccccc1)c1ccccc1)c1cccc(CCCCCC(=O)O)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYSLTR2 Q9NS75 2/20 0.49
CYSLTR1 Q9Y271 2/20 0.49
MAPT P10636 1/20 0.47
RXFP1 Q9HBX9 1/20 0.47
LTB4R Q15722 8/20 0.42
HDAC3 O15379 1/20 0.40
MAPK1 P28482 1/20 0.40
ADRA1A P35348 1/20 0.40
HDAC4 P56524 1/20 0.40
SLC6A3 Q01959 1/20 0.40
HDAC1 Q13547 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4841588 0.91 CYSLTR2 (0.42) CYSLTR2CYSLTR1MAPTRXFP1HDAC1
SCHEMBL4848474 0.88 CYP4F2 (0.39) CYSLTR2CYSLTR1LTB4RPPARGPPARA
SCHEMBL10290027 0.74 CYSLTR2 (0.60) CYSLTR2CYSLTR1MAPTRXFP1LTB4R
SCHEMBL10290026 0.74 CYSLTR2 (0.60) CYSLTR2CYSLTR1MAPTRXFP1LTB4R
SCHEMBL14297620 0.73 CYSLTR2 (0.58) CYSLTR2CYSLTR1MAPTRXFP1LTB4R
SCHEMBL1197247 0.71 MAPT (0.78) CYSLTR2CYSLTR1MAPTRXFP1LTB4R
SCHEMBL31584693 0.70 CYSLTR2 (0.58) CYSLTR2CYSLTR1MAPTRXFP1LTB4R
SCHEMBL765727 0.69 SMN1; SMN2 (0.58) CYSLTR2CYSLTR1MAPTRXFP1HDAC3
SCHEMBL8849634 0.69 LTB4R (0.60) CYSLTR2CYSLTR1MAPTRXFP1LTB4R
SCHEMBL2745021 0.68 LTA4H (0.38) PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE40558-E1 Therapeutic uses of di-aryl acid derivatives SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2008-10-28 US disclosed
CN-101070316-A Diaryl acid derivatives as PPAR receptor ligands AVENTIS PHARMA GMBH (DE) 2007-11-14 CN disclosed
CN-1331862-C Diaryl acid derivatives as PPAR receptor ligands AVENTIS PHARAMCEUTICALS PRODUC (DE) 2007-08-15 CN disclosed
US-6635655-B1 Agonists or antagonists of peroxisome proliferator-activated receptors AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-10-21 US disclosed